Yokohama, Japan

Yoshimi Kohayakawa

This inventor holds 59 USPTO granted patents, primarily in Ophthalmic Technology (CPC class 3512). Top assignee: Canon Kabushiki Kaisha. Active years: 1976-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimi Kohayakawa. Retrieved from https://idiyas.com/inventor/yoshimi-kohayakawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 98.3

Average Co-Inventor Count = 1.3

ph-index = 21

Forward Citations = 1,193(Granted Patents)

Forward Citations (Not Self Cited) = 1,039(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Yokohama, JA (1976)
  • Yokohama, JP (1978 - 2000)
  • Utsunomiya, JP (1999 - 2001)
  • Tochigi, JP (2004)
  • Tochigi-Ken, JP (2004)

Company Filing History:


Years Active: 1976-2004

Loading Chart...
Areas of Expertise:
Ophthalmologic Apparatus
Eye Examining Apparatus
Refractometer
Stereoscopic Image Apparatus
Visual Function Measuring
Fundus Camera
Keratometer
Optical Path Separation
Non-Contact Tonometer
Lens Meter
Intraocular Pressure Measurement
Ocular Refractivity
59 patents (USPTO):Explore Patents

Title: Innovations in Ophthalmology: The Contributions of Yoshimi Kohayakawa

Introduction

Yoshimi Kohayakawa, located in Yokohama, Japan, is a distinguished inventor known for his remarkable contributions to the field of ophthalmology, evidenced by a prolific portfolio of 59 patents. His inventions reflect a commitment to improving medical technology, particularly in the measurement and analysis of blood flow and oxygen concentration in ocular applications.

Latest Patents

Kohayakawa's latest innovations include two significant ophthalmologic apparatuses. The first apparatus is designed to measure blood flow velocity using the Doppler shift method. It features a first light source for the measurement and a second light source with a different wavelength used for tracking the blood vessel. This unique design allows for the simultaneous acquisition of blood oxygen concentration by analyzing the difference in reflectance between the two light sources.

The second patent further improves the operability of the measurement device. This ophthalmologic apparatus is equipped with a measuring optical system, a detection system to acquire alignment information, and a driving mechanism that enables the relative movement of the measuring optical system to the eye. It includes an operating device for manual control, along with a controller that can switch between automatic and manual alignment modes based on the detection system's input, enhancing both efficiency and accuracy during examinations.

Career Highlights

Yoshimi Kohayakawa has dedicated much of his career to advancing eye care technology while working at Canon Kabushiki Kaisha, a leading company recognized for its innovative solutions in imaging technology. His work at Canon highlights the intersection of technology and healthcare, demonstrating how innovation can directly impact medical diagnostics and patient outcomes.

Collaborations

Throughout his career, Kohayakawa has collaborated with notable colleagues, including Isao Matsumura and Yasuyuki Ishikawa. These partnerships underscore the importance of teamwork and shared expertise in driving advancements within the medical device industry.

Conclusion

Yoshimi Kohayakawa's extensive patent portfolio and his innovative ophthalmologic apparatuses illustrate his vital role in enhancing eye care technology. His contributions not only reflect a dedication to research and development but also showcase how collaboration in the field can lead to groundbreaking advancements in healthcare. As the industry continues to evolve, the work of pioneers like Kohayakawa will undoubtedly pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…